Adipose-derived MSC clusters (S.Biomedics)

Evidence outlook · lead readout

NCT04661644 · Critical Limb Ischemia

The reported results come from study designs that frequently fail to replicate under controlled conditions — see the rationale below.

NCT04661644: The study was nonrandomized, open-label, and had no placebo or standard-treatment control arm; it enrolled 20 participants across sequential dose groups. Its primary measures included clinical outcomes such as ischemic pain, pain-free walking distance, and ulcer size, but no primary endpoint results have been posted.